DarioHealth

Company Overview

Snapshot

Founded in September 2011 by Dov Oppenheim, DarioHealth operates with 201–500 employees. The company has raised a total of $268.11 million across 18 funding rounds from 13 investors. In February 2013, DarioHealth went public on NASDAQ.

Business overview

DarioHealth is a global digital therapeutics company focused on transforming chronic condition management. The company provides AI-powered digital therapeutic solutions, including highly-rated diabetes and hypertension offerings. These solutions deliver adaptive, personalized experiences through evidence-based interventions, high-quality software, coaching, and clinically proven digital tools to drive behavior change and improve health outcomes. Operating at the intersection of life sciences, behavioral science, and software technology, DarioHealth serves markets in the United States, Canada, Germany, the United Kingdom, Italy, Australia, New Zealand, and the Netherlands, and is expanding into new chronic conditions and geographic regions.

Strategic signal

In September 2025, DarioHealth announced a strategic review following multiple unsolicited inbound expressions of interest. This indicates significant market validation and potential for a major corporate transaction, suggesting a pivotal moment for the company's future ownership or strategic direction.

Company Intelligence Q&A

What was a significant recent strategic development for DarioHealth?

In September 2025, DarioHealth announced it was undergoing a strategic review after receiving multiple unsolicited expressions of interest, signaling potential major corporate changes.

What was DarioHealth's most recent funding event?

In July 2026, DarioHealth announced the pricing of a registered direct offering of common stock, valued at $23.5 million.

What was a key acquisition for DarioHealth in 2024?

In February 2024, DarioHealth acquired Twill, a digital health company, aiming to create a comprehensive digital health platform for prevalent chronic conditions.

What new research did DarioHealth publish in September 2023?

In September 2023, DarioHealth published new research demonstrating clinically significant reductions in depression through its digital behavioral health programs.

What strategic collaboration did DarioHealth announce in October 2025?

In October 2025, DarioHealth announced a strategic collaboration with OneStep to integrate smartphone-only, clinical-grade fall risk assessment technology into Dario's digital health multi-condition platform.